| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |